Electrolyte Disturbances in Chronic Liver Disease: Correlation of Serum Sodium, Potassium, and Magnesium Levels with Disease Severity
DOI:
https://doi.org/10.65129/medical.v1i1.10Keywords:
Cirrhosis, CTP, Electrolytes, Magnesium, MELD, Potassium, SodiumAbstract
Background: Electrolyte imbalances are common in cirrhosis and may indicate disease progression. While magnesium has been explored as a marker of severity, limited studies evaluate the combined correlation of sodium, potassium, and magnesium with chronic liver disease severity. Aims: To estimate serum sodium, potassium, and magnesium levels in cirrhosis patients, and to assess their correlation with the severity of liver disease as measured by Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores. Methods: This cross-sectional study enrolled 121 cirrhotic patients. Serum electrolyte levels were measured and correlated with MELD and CTP scores. Statistical tests were done using SPSS v26. Results: Magnesium levels declined significantly across worsening CTP classes (p = 0.012), and inversely correlated with MELD (r = -0.336, p < 0.001). However, sodium (p = 0.22) and potassium (p = 0.792) levels showed no significant variation across CTP classes. Magnesium also negatively correlated with bilirubin (r = -0.258, p = 0.004) and positively with albumin (r = 0.239, p = 0.008). Conclusion: Magnesium correlates significantly with cirrhosis severity, suggesting its utility as a prognostic marker. Sodium and potassium did not show a consistent association. Routine evaluation of magnesium may enhance the assessment of cirrhosis progression.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Medical and Medical Specialities

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Peng X, Xiang R, Li X, Tian H, Li C, Peng Z, et al. Magnesium deficiency in liver cirrhosis: A retrospective study. Scand J Gastroenterol. 2021; 56(4):463-468. https://doi.org/10.1080/00365521.2021.1888154 PMid:33646920
2. Llibre-Nieto G, Lira A, Vergara M, Solé C, Casas M, PuigDiví V, et al. Micronutrient deficiencies in patients with decompensated liver cirrhosis. Nutrients. 2021; 13(4):1249. https://doi.org/10.3390/nu13041249 PMid:33920134 PMCid:PMC8069759
3. Liu M, Yang H, Mao Y. Magnesium and liver disease. Ann Transl Med. 2019; 7(20):578. https://doi.org/10.21037/atm.2019.09.70 PMid:31807559 PMCid:PMC6861788
4. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005; 42 Suppl(1):S100-S107. https://doi.org/10.1016/j.jhep.2004.11.015 PMid:15777564
5. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-649. https://doi.org/10.1002/bjs.1800600817 PMid:4541913
6. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464-470. https://doi.org/10.1053/jhep.2001.22172 PMid:11172350
7. Wu L, Zhu X, Fan L, Kabagambe EK, Song Y, Tao M, et al. Magnesium intake and mortality due to liver diseases: Results from NHANES III. Sci Rep. 2017; 7(1):17913. https://doi.org/10.1038/s41598-017-18076-5 PMid:29263344 PMCid:PMC5738415
8. Chavan M, Nadagoudar SB, Boke U. Study of serum magnesium in liver disease. J Evid Based Med Healthc. 2021; 8(42):3646.
9. Veena G, James R. Prevalence of hypomagnesemia in cirrhosis of the liver. Asian J Pharm Clin Res. 2022; 15(8): 92-95.
10. Rani P, Goel R, Madaan H. Assessment of serum magnesium levels in liver cirrhosis and its correlation with severity of disease. Int J Acad Med Pharm. 2024; 6(3):462-466.
11. Das B, Chandra P, Thimmaraju KV. Serum magnesium level in patients with liver cirrhosis. Int J Biol Med Res. 2011; 2(3):709-711.
12. Gowda P, Tembad M. Study of serum magnesium in liver diseases. J Evol Med Dent Sci. 2015; 4:3047-3056. https://doi.org/10.14260/jemds/2015/443
13. Koivisto M, Valta P, Höckerstedt K, Lindgren L. Magnesium depletion in chronic terminal liver cirrhosis. Clin Transplant. 2002; 16(5):325-328. https://doi.org/10.1034/j.1399-0012.2002.01141.x PMid:12225427
14. Kar K, Dasgupta A, Bhaskar MV, Sudhakar K. Alteration of micronutrient status in compensated and decompensated liver cirrhosis. Indian J Clin Biochem. 2014; 29(2):232-237. https://doi.org/10.1007/s12291-013-0349-5 PMid:24757308 PMCid:PMC3990801
15. Nangliya V, Sharma A, Yadav D, Sunder S, Nijhawan S, Mishra S. Study of trace elements in liver cirrhosis patients. Biol Trace Elem Res. 2015; 165(1):35-40. https://doi.org/10.1007/s12011-015-0237-3 PMid:25613584
16. Poikolainen K, Alho H. Magnesium treatment in alcoholics: A randomized clinical trial. Subst Abuse Treat Prev Policy. 2008; 3:1. https://doi.org/10.1186/1747-597X-3-1 PMid:18218147 PMCid:PMC2265283
17. Gullestad L, Dolva LØ, Birkeland K, et al. Oral versus intravenous magnesium in patients with deficiency. Magnes Trace Elem. 1991;10(1):11-16.
18. Eshraghian A, Nikeghbalian S, Geramizadeh B, Malek-Hosseini SA. Magnesium and non-alcoholic fatty liver. United Eur Gastroenterol J. 2017; 6(1):97-103. https://doi.org/10.1177/2050640617707863 PMid:29435319 PMCid:PMC5802673
19. Dumea M, Cimpoesu DC, Nechifor M. Divalent cation profile in variceal bleeding. Rev Med Chir Soc Med Nat Iasi. 2015; 119(4):1166-1173.
20. Rahelić D, Kujundzić M, Romić Z, et al. Trace elements in liver cirrhosis. Coll Antropol. 2006;30(3):523-528.
